BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 12196897)

  • 21. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
    Sternberg CN
    Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical factors influence bladder cancer outcomes: a cooperative group report.
    Herr HW; Faulkner JR; Grossman HB; Natale RB; deVere White R; Sarosdy MF; Crawford ED
    J Clin Oncol; 2004 Jul; 22(14):2781-9. PubMed ID: 15199091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview of bladder cancer trials in the European Organization for Research and Treatment.
    de Wit R;
    Cancer; 2003 Apr; 97(8 Suppl):2120-6. PubMed ID: 12673705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neoadjuvant chemotherapy for invasive bladder cancer].
    Kageyama Y; Kihara K
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1838-44. PubMed ID: 11729476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy for advanced bladder cancer.
    Roth BJ
    Semin Oncol; 1996 Oct; 23(5):633-44. PubMed ID: 8893874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy.
    Aparicio AM; Elkhouiery AB; Quinn DI
    Urol Clin North Am; 2005 May; 32(2):217-30, vii. PubMed ID: 15862619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Why use chemotherapy in cancer of the bladder? What are the initial limitations].
    Maraninchi D; Viens P
    Ann Urol (Paris); 1994; 28(6-7):334-7. PubMed ID: 7534457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of adjuvant chemotherapy for locally advanced bladder cancer.
    Lehmann J; Retz M; Stöckle M
    World J Urol; 2001 Apr; 19(2):133-40. PubMed ID: 11374316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Birtle AJ; Huddart RA
    BJU Int; 2006 Jun; 97(6):1348; author reply 1348-50. PubMed ID: 16686740
    [No Abstract]   [Full Text] [Related]  

  • 30. Overview of bladder cancer trials in the Radiation Therapy Oncology Group.
    Shipley WU; Kaufman DS; Tester WJ; Pilepich MV; Sandler HM;
    Cancer; 2003 Apr; 97(8 Suppl):2115-9. PubMed ID: 12673704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
    Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
    Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of chemotherapy in the management of bladder cancer].
    Ismaili N; Amzerin M; Elmajjaoui S; Droz JP; Flechon A; Errihani H
    Prog Urol; 2011 Jun; 21(6):369-82. PubMed ID: 21620296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer.
    Pectasides D; Pectasides M; Economopoulos T
    Cancer Treat Rev; 2006 Oct; 32(6):456-70. PubMed ID: 16935429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Place of chemotherapy in the treatment of invasive bladder tumors].
    Pariente JL; Theodore C; Davin JL; Rischmann P; Chopin D
    Prog Urol; 1999 Apr; 9(2):219-24. PubMed ID: 10370944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bladder cancer chemotherapy practice study].
    Clippe C; Clippe S; Yzebe D; Flechon A; Droz JP
    Prog Urol; 2002 Sep; 12(4):609-14. PubMed ID: 12463119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy.
    Komai Y; Fujii Y; Okubo Y; Yamamoto S; Kawakami S; Yonese J; Fukui I
    Int J Urol; 2008 Oct; 15(11):971-5. PubMed ID: 18775029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review.
    Pectasides D; Pectasides M; Nikolaou M
    Eur Urol; 2005 Jul; 48(1):60-7; discussion 67-8. PubMed ID: 15967253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies.
    Garcia JA; Dreicer R
    Nat Clin Pract Urol; 2005 Jan; 2(1):32-7. PubMed ID: 16474574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.